John Libbey Eurotext

Hématologie

Mortalité élevée des adolescents atteints de drépanocytose homozygote avec antécédents d’accident vasculaire cérébral en rapport avec l’arrêt des programmes transfusionnels lors de la transition pédiatrie-secteur adulte aux États-Unis Volume 22, numéro 5, Septembre-Octobre 2016

  • [1] McLaughlin J.F., Ballas S.K. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program. Transfusion. 2016;56:1014-1021.
  • [2] Gueguen A., Mahevas M., Nzouakou R., Hosseini H. Sickle cell disease stroke throughout life: a retrospective study in an adult referral center. Am J Hematol. 2014;89:267-272.
  • [3] Quinn C.T., Rogers Z.R., Mc Cavit T.C., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115:3447-3452.
  • [4] Stollon N.B., Paine C.W., Lucas M.S., Brumley L.D. Transitioning adolescents and young adults with sickle cell disease from pediatric to adult health care. J Pediatr Hematol Oncol. 2015;37:577-583.
  • [5] de Montalembert M., Guitton C. Transition from paediatric to adult care for patients with sickle cell disease (French referral centre for SCD). Br J Haematol. 2014;164:630-635.